by Brandt Capone, PT, CSCS
Tommy John surgery—formally known as ulnar collateral ligament (UCL) reconstruction—originated in 1974 when Los Angeles Dodgers pitcher Tommy John suffered a complete UCL tear, an injury considered career‑ending at the time. Team physician Dr. Frank Jobe performed a groundbreaking procedure on September 25, 1974, replacing John’s damaged ligament with a tendon from his forearm and giving him only 1% odds of returning to Major League Baseball.
Defying expectations, John returned to the mound in 1976 and went on to pitch 14 more seasons, ultimately winning 288 career games and earning four All‑Star selections. His successful comeback transformed the landscape of sports medicine, and the procedure soon became known simply as “Tommy John surgery.”
Over the next five decades, orthopedic surgeons refined Dr. Jobe’s original technique—improving graft selection, nerve management, and fixation methods. Modern variations such as the docking technique have further increased success rates, making UCL reconstruction a routine and often career‑saving procedure for pitchers and overhead athletes. Today, more than 2,600 MLB players and thousands of amateur athletes have undergone Tommy John surgery.
Tommy John passed away on August 15, 2026, at the age of 83, leaving behind a legacy that reshaped both baseball and orthopedic surgery. His courage in undergoing an unproven operation—and his remarkable return to elite performance—continues to benefit generations of athletes.
